MTOR and colorectal cancer: TAMs promote oxaliplatin resistance in colorectal cancer [32]; M2-polarized TAMs are responsible for cancer resistance to cisplatin [33], and chemokines secreted by TAMs activate the PI3K/Akt/mTOR signalling pathway, thereby promoting resistance [34].